Biomedical subjects

G Baerveldt

Publications and source records attributed to G Baerveldt.

58 records · Page 4Linked to original sources

PubMed1981

The epidemiology and geographical distribution of trachoma in Lebowa.

The prevalence of active trachoma and its potentially blinding sequelae have been estimated in ten settlements scattered throughout rural Lebowa. The disease represents a major public health problem only in northern Lebowa where 25% of subjects over 60 years of age were found to be suffering form visual disability as a result of the infection. Although the disease is endemic in most other parts of lebowa it rarely causes blindness and impaired vision. A rational approach to the control of trachoma in the area which takes into account both local considerations and recent advances in the knowledge of the epidemiology of the disease is recommended.

Adolescent↗

PubMedDate not supplied

Glaucoma associated with uveitis.

Raised intraocular pressure is a common and frequently serious complication of anterior uveitis. The milieu of inflammatory cells, the mediators they release, and the corticosteroid therapy used to treat the uveitis can participate in the pathogenesis of uveitic glaucoma. These factors alter the normal anatomic structure of the anterior chamber and angle, influencing aqueous production and outflow. These changes act to disrupt the homeostatic mechanisms of intraocular pressure control. Structural changes in the angle can be acute, such as in secondary angle closure with pupillary block glaucoma, or chronic, such as combined steroid-induced and secondary open angle glaucoma. Management of uveitic glaucoma may be difficult because of the numerous mechanisms involved in its pathogenesis. Diagnostic and therapeutic decisions are guided by careful delineation of the pathophysiology of each individual case. The goal of treatment is to minimize permanent structural alteration of aqueous outflow and to prevent damage to the optic nerve head. This article reviews the pathogenesis of uveitic glaucoma, with specific attention to etiology. Medical and surgical therapies are also discussed, with emphasis on the more recent developments in each category.

Glaucoma↗

PubMedDate not supplied

Primary iris stromal cysts.

The clinical and histopathologic features of four cases of primary iris stromal cysts are reported. Though the histologic characteristics of iris stromal cysts have been well described by previous authors, their exact embryologic origin is not clear. Also, because of the relatively uncommon nature of these lesions, the most appropriate management is not well defined. In our series, routine histopathologic studies were supplemented with immunohistochemical stains for cytokeratins and S100 proteins, results of which suggested an origin from surface ectoderm. All of our patients required surgical management, although spontaneous involution of a temporary nature was observed in one case, and recurrences following incomplete removal were common.

Child↗

PubMedDate not supplied

Trabeculectomy in pseudophakic patients: postoperative 5-fluorouracil versus intraoperative mitomycin C antiproliferative therapy.

Trabeculectomy outcome in pseudophakic glaucoma patients treated with mitomycin C (MMC) or 5-fluorouracil (5-FU) was analyzed retrospectively in 46 cases (46 eyes). Thirty patients received intraoperative MMC; 16, 5-FU. There were no significant differences between the two groups in terms of preoperative data (demographics, number of previous filtering procedures, visual acuity, and intraocular pressure [IOP]). After a mean follow up of 13.4 +/- 8.1 and 11.5 +/- 5.8 months for the 5-FU and MMC groups, respectively, 12 5-FU eyes (75%) and 21 MMC eyes (70%) were deemed at least qualified successes (IOP < or = 21 mm Hg with or without antiglaucoma medications). Six (37.5%) of the 5-FU eyes and 13 (43.3%) of the MMC eyes were complete successes (IOP < or = 21 mm Hg without antiglaucoma medications). There were no significant differences between the two groups in terms of duration of follow up, number of qualified successes, and number of complete successes (P = .35, .9, and .7, respectively). Nor were there any significant differences in the mean final IOPs and visual acuities. Excluding transient corneal effects associated with 5-FU therapy, there were no significant differences in the frequency of postoperative complications. These results suggest that 5-FU and MMC antiproliferative therapy are associated with similar short-term success rates and postoperative complications.

Aged↗